You are using an older browser version. Please use a supported version for the best MSN experience.

'COVID-19 pandemic still not over': NITI Aayog's VK Paul urges people to take coronavirus precaution dose

Times Now logo Times Now 18-08-2022 Times Now Digital
'covid-19 pandemic still not over': niti aayog's vk paul urges people to take coronavirus precaution dose © Provided by Times Now 'covid-19 pandemic still not over': niti aayog's vk paul urges people to take coronavirus precaution dose

New Delhi: Niti Aayog member (health) Dr VK Paul has urged the people to take precaution or booster dose of vaccines against COVID-19 as India is reporting nearly 10,000 fresh infections daily.

“We need to protect ourselves and need to take precaution dose. Those who have taken a second dose and exceeded 6 months should take the precautionary dose soon,” Dr Paul told news agency ANI.

Talking about the slow rate of vaccination, he said that there is no dearth of vaccine availability and hence the eligible persons should get themselves vaccinated with the precaution doses.

“It was said there was slowness in the starting but in 75 days to Amrit Mahotsav, there has been an improvement in inoculation rate and it is satisfactory,” he said.

Presenting the comparative data between the rate of inoculation earlier and in the last month, he said, “It was 8 percent of precaution dose vaccination rate and now it has reached 17 percent at present within a month but this speed needs to increase.”

“There is no dearth of vaccines and eligible beneficiaries should go to the vaccination centre. COVID-19 is still around and you are only covered when you take precaution dose,” Dr Paul said.

He further said that three vaccines are available to be taken as precaution dose, includng Covaxin, Covishield and recently inducted Corbevax.

Corbevax vaccine approved for precaution dose for heterologous or mix-match option, he said.

Research on vaccines is still going on, he said, adding that the intranasal vaccine is in advanced stage and work on the mRNA vaccine is also progressing.

“mRNA vaccine is also being worked on, intranasal vaccine is in advanced stage and people are also talking about Omicron specific vaccine should be made. These moves should be continued and we all have the capability. Research is going on,” he added.

More from Times Now

Times Now
Times Now
image beaconimage beaconimage beacon